Trial Profile
Phase IIIB, Double Blind, Placebo Controlled, International, Multicenter, Parallel Group Study, to Assess the Efficacy and Safety of Testim Gel in Combination with a Phosphodiesterase V Inhibitor (Tadalafil), in Male Patients with Low or <Borderline> Baseline Serum Testosterone Levels and Erectile Dysfunction
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 28 Mar 2022
Price :
$35
*
At a glance
- Drugs Testosterone (Primary) ; Tadalafil
- Indications Erectile dysfunction; Hormone deficiency
- Focus Biomarker; Therapeutic Use
- Acronyms TESTIMED
- Sponsors Ipsen Limited
- 28 Mar 2022 This trial has been completed in Belgium (End Date: 28 Feb 2007), according to European Clinical Trials Database record.
- 10 Oct 2020 Status changed from recruiting to discontinued.
- 01 Jun 2011 This trial is recruiting in the United Kingdom but has been discontinued in Italy.